The European Patent Office has approved the patent, number EP3004136, filed by Dr. Menegatti for the purification of IgG using peptoid affinity ligands.  We think this is the beginning of an incredible journey with a new set of chemistries, one that will have many of the positive traits of our lab’s traditional expertise with peptides but the added bonuses of chemical stability.  More peptoid work from us is on the horizon as we continue to work on the cutting edge of biotechnology and bioprocessing.

Read more about the patent and the European Union patent office here.